Conference Call – 8:30am Thursday,
November 15th
New Website and Investor Presentation Now Live at GeneNews.Com
TORONTO, Nov. 13, 2018 /CNW/ - GeneNews Limited
("GeneNews" or the "Company") (TSX:GEN) today announced that it
will release its Third Quarter 2018 financial results before
markets open on Thursday, November 15,
2018. GeneNews' Chairman and CEO, James R Howard-Tripp, will
host a conference call at 8:30 am ET
on November 15, to review the
financial results and discuss business developments for the period.
He will also present the new Investor Presentation and website.
Third Quarter 2018 Results Conference Call
Details:
Date: Thursday, November 15,
2018
Time: 8:30 am EST
Live Call:
Local - Toronto (+1) 416 764 8609
Toll Free - North America (+1) 888 390 0605
Conference ID: : 40595231
Playback Phone Numbers:
Local – Toronto (+1) 416 764 8677
Toll Free – North America (+1) 888
390 0541
Playback Passcode: 595231#
Playback Expiration Date: Thursday, November
22, 2018 11:59 PM
The call will also be broadcast live and archived on the
Company's website at www.GeneNews.com in the Investor's
section.
About GeneNews
GeneNews, an innovator in the liquid
biopsy space, is committed to becoming a leader in advanced
diagnostics and personalized medicine, serving as a strong
commercialization outlet for early detection of cancer and other
chronic diseases. Our mission is to identify, assess and make
commercially available a comprehensive menu of diagnostics that
provide physicians and patients with personalized clinical
intelligence and actionable information to improve health outcomes
through the early diagnosis of disease. Our Richmond, Virginia-based Innovative Diagnostic
Laboratory clinical reference lab specializes in traditional and
advanced clinical evidence-based blood testing that helps find,
understand, and address cancer risk in patient populations.
Currently, IDL offers risk assessment blood tests for four
prevalent cancer types - colon, lung, prostate and breast.
GeneNews' common shares trade on the Toronto Stock Exchange under
the symbol 'GEN'. More information on GeneNews and IDL can be found
at www.GeneNews.com and www.myinnovativelab.com, respectively.
Forward-Looking Statements
This press release contains
forward-looking statements identified by words such as "expects",
"will" and similar expressions, which reflect the Corporation's
current expectations regarding future events. The forward-looking
statements involve risks and uncertainties that could cause the
Corporation's actual events to differ materially from those
projected herein. Investors should consult the Corporation's
ongoing quarterly filings and annual reports for additional
information on risks and uncertainties relating to these
forward-looking statements. The reader is cautioned not to rely on
these forward-looking statements. The Corporation disclaims any
obligation to update these forward-looking statements, except as
required by law.
View original
content:http://www.prnewswire.com/news-releases/genenews-announces-third-quarter-2018-results-investor-call-300749726.html
SOURCE GeneNews Limited